ArticleJAMA network open2020

Assessment of Cancer Therapy Evaluation Program Advocacy and Inclusion Rates of People Living With HIV in Anti-PD1/PDL1 Clinical Trials.

Joshua E Reuss et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.